Showing results (111-120 of 586) with videos related to
Sort By:
Pageof 59
The Lancet. Oncology|July 2, 2021
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trialJawad Fares, Atique U Ahmed, Ilya V Ulasov, et al.Nature Communications|December 16, 2025
Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxelMark W Youngblood, Abha Kumari, Yoon-Tae Kang, et al.Physical Review Letters|January 7, 2021
Results on Low-Mass Weakly Interacting Massive Particles from an 11 kg d Target Exposure of DAMIC at SNOLABA Aguilar-Arevalo, D Amidei, D Baxter, et al.Neuro-Oncology|July 19, 2024
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomasKwang-Soo Kim, Karl Habashy, Andrew Gould, et al.Nature Communications|June 6, 2024
Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomasVíctor A Arrieta, Andrew Gould, Kwang-Soo Kim, et al.Physical Review Letters|November 26, 2019
Constraints on Light Dark Matter Particles Interacting with Electrons from DAMIC at SNOLABA Aguilar-Arevalo, D Amidei, D Baxter, et al.The Journal of Clinical Investigation|March 17, 2025
Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma modelsDeepa Seetharam, Jay Chandar, Christian K Ramsoomair, et al.Physical Review Letters|April 22, 2017
First Direct-Detection Constraints on eV-Scale Hidden-Photon Dark Matter with DAMIC at SNOLABA Aguilar-Arevalo, D Amidei, X Bertou, et al.Biorxiv : the Preprint Server for Biology|October 28, 2024
Targeting ZNF638 activates antiviral immune responses and potentiates immune checkpoint inhibition in glioblastomaDeepa Seetharam, Jay Chandar, Christian K Ramsoomair, et al.Annals of Internal Medicine|February 21, 2023
Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort StudyManuel Zorzi, Giulio Antonelli, Claudio Barbiellini Amidei, et al.Pageof 59